NCT06307028

Brief Summary

In this project, the investigators will provide a new HIV prevention training and empowerment sessions to Black women in Washington D.C., Atlanta and New Orleans, who are at high risk for getting HIV. This training is tailored to the experience of Black women and seeks to reduce the high HIV transmission rates in the Black community.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 8, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 23, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 13, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 13, 2024

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

April 28, 2026

Completed
Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

10 months

First QC Date

February 23, 2024

Results QC Date

December 15, 2025

Last Update Submit

April 7, 2026

Conditions

Keywords

Black womenHIV

Outcome Measures

Primary Outcomes (4)

  • Feasibility of the Intervention Scale

    5-item scale, range 1 (strongly disagree) to 5 (strongly agree). Lower values indicate less feasibility and higher values indicate more feasibility; adapted from Weiner, B.J., Lewis, C.C., Stanick, C. et al. Psychometric assessment of three newly developed implementation outcome measures. Implementation Sci 12, 108 (2017). https://doi.org/10.1186/s13012-017-0635-3

    At the time of post-test (after 6 sessions)

  • Acceptability of the Intervention Scale

    5-item scale, range 1 (strongly disagree) to 5 (strongly agree). Lower scores indicate less acceptability, and higher scores indicate more acceptability. adapted from Weiner, B.J., Lewis, C.C., Stanick, C. et al. Psychometric assessment of three newly developed implementation outcome measures. Implementation Sci 12, 108 (2017). https://doi.org/10.1186/s13012-017-0635-3

    At the time of post-test (after 6 sessions).

  • Appropriateness of the Intervention Scale

    5-item scale, range 1 (strongly disagree) to 5 (strongly agree). Lower scores indicate lower appropriateness, and higher scores indicate higher appropriateness. adapted from Weiner, B.J., Lewis, C.C., Stanick, C. et al. Psychometric assessment of three newly developed implementation outcome measures. Implementation Sci 12, 108 (2017). https://doi.org/10.1186/s13012-017-0635-3

    At the time of the post-test (after 6 sessions)

  • Behavioral Intentions (Post-test)

    Participants' intentions to use PrEP within the next 12 months. range 1 (strongly disagree) to 5 (strongly agree). Lower scores indicate lower behavioral intentions and higher scores indicate higher behavioral intentions. adapted from Scott RK, Hull SJ, Huang JC, et al. Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.C. Arch Sex Behav. 2022;51(5):2613-2624. doi:10.1007/s10508-021-02274-4

    This occurred immediately before session 1 and again after session 6 (42 days after the first session was delivered; 42 days post baseline)

Secondary Outcomes (6)

  • Number of Participants Enrolled Out of All Eligible Participants

    At the end of each Session 1

  • Number of Participants Enrolled That Are Potentially PrEP Eligible Black Women

    At the time of session 1

  • Acceptability of the Intervention Delivery (Acceptability)

    At the time of post-test (after 6 sessions)

  • Participant Retention

    At the time of post-test (after 6 sessions).

  • Visual Confirmation of Self-reported PrEP Uptake

    At the time of post-test (after 6 sessions)

  • +1 more secondary outcomes

Study Arms (1)

SISTA-P Intervention

EXPERIMENTAL

Participants will complete four sessions lasting up to three hours each over the course of one week. The sessions will be conducted by two facilitators with a technical monitor and the PI observing. Core elements of SISTA-P are: (1) small group discussions, modeling and role-play that facilitate repetition, reinforcement and sequential approximation; (2) skilled facilitators; (3) gender and culturally specific materials to enhance pride and self-worth; (4) teaching negotiation, self-advocacy; and (5) HIV prevention relevant skills; (6) discussing gender and culture-specific barriers and facilitators to prevention; and (7) enhancing HIV prevention norms and self-efficacy. Each discussion group will consist of up to 15 participants and each cycle will consist of one group. Participants will be asked to complete a follow up survey and two booster sessions. They will also be asked to submit photo-confirmation of PrEP prescription to the research team.

Behavioral: SISTA-P Intervention

Interventions

This intervention is a small group discussion designed specifically for Black women. The sessions cover topics including: self pride and self-care; HIV \& PrEP education; assertiveness skills training; coping skills; skills practice; and barriers and facilitators to HIV prevention and PrEP.

SISTA-P Intervention

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBlack women are eligible for this study.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Black women are eligible if you:
  • Have sex with men
  • Are age 18+
  • Live in Washington D.C., Atlanta, GA, or New Orleans, LA
  • Are not HIV+

You may not qualify if:

  • HIV+

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Women's Collective

Washington D.C., District of Columbia, 20002, United States

Location

Rutgers University

New Brunswick, New Jersey, 08854, United States

Location

MeSH Terms

Conditions

Health Risk BehaviorsBehaviorHealth Behavior

Results Point of Contact

Title
Dr. Shawnika J. Hull
Organization
Rutgers University

Study Officials

  • Shawnika Hull, PhD

    Rutgers University School of Communication and Information

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Department of Communication

Study Record Dates

First Submitted

February 23, 2024

First Posted

March 12, 2024

Study Start

January 8, 2024

Primary Completion

November 13, 2024

Study Completion

November 13, 2024

Last Updated

April 28, 2026

Results First Posted

April 28, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

As of now, there are no plans to share the IPD.

Locations